
Requip-Prolib — ropinirole 8 mg, prolonged-release tablets, 28 pcs
Brand: GSK
+ delivery from €40
Requip-Prolib. Active ingredient — ropinirole, 8 mg. Dosage form: prolonged-release tablets. Pack size — 28 tablets. National code (CN) 660737.
Key information
Full description
Requip-Prolib 8 mg, National code (CN) 660737. The highest strength of the prolonged-release form in the catalog. High doses of ropinirole are prescribed in the maintenance phase of therapy, once dose adjustment is complete. The daily dose may then be made up with one tablet or a combination of several — the regimen is specified by the neurologist. During long-term therapy with dopamine receptor agonists, the doctor periodically assesses the patient's condition, including daytime sleepiness and changes in behaviour. These symptoms should be mentioned at appointments, even if they seem unrelated to the treatment. Stopping the medicine abruptly is not acceptable.
Composition
one prolonged-release tablet contains 8 mg of ropinirole.
Administration
oral, once a day, swallowed whole, at the same time each day.
Storage conditions
in the original package, out of the reach of children.
Frequently asked questions
Which phase of therapy is this strength for?
For maintenance, once dose adjustment is complete.
What is important to tell the doctor at appointments?
About daytime sleepiness and changes in behaviour, even if they seem unrelated to the treatment.
Can I stop taking it all at once?
No, stopping abruptly is not acceptable.
How to order
Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.
This information is for reference only. Consult a doctor and read the official package leaflet before use.